
Abiomed (NASDAQ:
ABMD) has developed a portfolio of heart support and recovery products
and services which offer healthcare professionals an array of choices
across a broad clinical spectrum. From the catheterization lab to the
surgical suite, together with interventional cardiologists and surgeons,
Abiomed is dedicated to providing the most advanced medical technologies
to heart patients, with the ultimate goal of heart recovery and improved
quality of life.

Accumetrics
is focused on developing point-of-care platform-technology diagnostic
products in the cardiovascular and neurovascular disease area.

BioForm Medical, Inc.
(BioForm) develops and commercializes injectable implant products for
soft and hard tissue augmentation. BioForm is dedicated to improving
patients‚ lives by providing high quality, innovative, safe and
effective medical products for use in the plastic surgery, urology and ENT markets.

Orthopedic Resources, Inc., (dba Bledsoe Brace
Systems)
is a leader in the orthopedic bracing market. Founded in
1982, it was the first company to develop a post-operative knee brace,
and has continued to build on its 25-year reputation of quality clinical
products and design leadership. Bledsoe’s products are used both
domestically and internationally by orthopedic surgeons, podiatrists, orthotists, and physical therapists to address musculoskeletal disorders
of their patients by supporting and protecting injured or weakened
joints.

Clear Vascular, Inc was founded by Essex Woodlands Health
Ventures in 2005. The primary objective of the company is to develop
innovative cardiovascular products.

InSound Medical
develops minimally invasive hearing devices for the 26 million hearing
impaired market. The company's proprietary hearing products are
implanted inconspicuously in the ear canal through a nonsurgical
procedure.

LipoSonix
is a medical device company focused on the development of proprietary
technology for noninvasive cosmetic surgery applications.

Medlogics is an early stage medical device company developing
a broad platform technology for innovative drug delivery. The initial
focus is product development of polymer-free stent drug delivery.

MicroPort
Medical (Shanghai) Co. Ltd. provides leading edge technologies
and products for physicians and their patients. In close cooporation
with physicians and scientists worldwide, MicroPort has developed a
range of interventional vascular products with the objective of growing
MicroPort into a world wide market leading company, with continuous
innovation and development of new interventional vascular products and
technologies.

Nellix, Inc., is a
privately funded, medical device startup company located in Mountain
View, CA. Nellix is actively developing novel solutions to vascular
diseases affecting millions of patients world wide.

NeoVista, Inc. is developing an intraocular epiretinal radiation device
intended for the treatment of the wet form of Age-Related Macular
Degeneration (AMD).

Novacept
designs, develops, manufactures and markets innovative therapeutic
devices to improve the quality of women's healthcare in a cost-effective
manner. Novacept was sold to
Cytyc Corporation in March 2004.

Oraya Therapeutics, Inc. is a privately held company
developing medical devices.

Orthovita is a unique spine/orthopaedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies. Their experience lies in developing and distributing novel, high-tech, synthetic-based biomaterial products. Orthovita currently has four key commercial product platforms: Vitoss Bone Graft Substitute, Vitagel Surgical Hemostat, Cortoss Synthetic Cortical Bone, and Imbibe Delivery and Disposable Systems.

Proteus Biomedical
was founded in 2001 to apply its state-of-the-art
semiconductor technology to the treatment of cardiovascular disease.

Sontra Medical, Inc.
develops ultrasound based devices and systems to improve glucose
monitoring methods for diabetics and to expand the number of drugs that
may be delivered transdermally.

Sound ID
develops proprietary sound-source signal enhancement technology
deployable in a wide variety of audio products.

St. Francis Medical Technologies, Inc.,
develops new, minimally invasive technologies and procedures for the
orthopedic and neurosurgical spinal surgery markets.

Thermage
is a medical device company in the early stages of developing a radio
frequency-based device designed for the treatment of skin in dermatology
and plastic surgery applications.
|